BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

858 related articles for article (PubMed ID: 11722842)

  • 1. Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression.
    Wu GJ; Wu MW; Wang SW; Liu Z; Qu P; Peng Q; Yang H; Varma VA; Sun QC; Petros JA; Lim SD; Amin MB
    Gene; 2001 Nov; 279(1):17-31. PubMed ID: 11722842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of a human cell adhesion molecule, MUC18, in prostate cancer cell lines and tissues.
    Wu GJ; Varma VA; Wu MW; Wang SW; Qu P; Yang H; Petros JA; Lim SD; Amin MB
    Prostate; 2001 Sep; 48(4):305-15. PubMed ID: 11536311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of mouse MUC18 cDNA gene, and correlation of MUC18 expression in mouse melanoma cell lines with metastatic ability.
    Yang H; Wang S; Liu Z; Wu MH; McAlpine B; Ansel J; Armstrong C; Wu G
    Gene; 2001 Mar; 265(1-2):133-45. PubMed ID: 11255016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ectopical expression of human MUC18 increases metastasis of human prostate cancer cells.
    Wu GJ; Peng Q; Fu P; Wang SW; Chiang CF; Dillehay DL; Wu MW
    Gene; 2004 Mar; 327(2):201-13. PubMed ID: 14980717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of MUC18 correlates with the metastatic progression of mouse prostate adenocarcinoma in the TRAMP model.
    Wu GJ; Fu P; Chiang CF; Huss WJ; Greenberg NM; Wu MW
    J Urol; 2005 May; 173(5):1778-83. PubMed ID: 15821586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily.
    Lehmann JM; Riethmüller G; Johnson JP
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):9891-5. PubMed ID: 2602381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of CD9 expression during prostate carcinoma progression is associated with CD9 mRNA modifications.
    Wang JC; Bégin LR; Bérubé NG; Chevalier S; Aprikian AG; Gourdeau H; Chevrette M
    Clin Cancer Res; 2007 Apr; 13(8):2354-61. PubMed ID: 17406028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct correlation between MUC18 expression and metastatic potential of human melanoma cells.
    Luca M; Hunt B; Bucana CD; Johnson JP; Fidler IJ; Bar-Eli M
    Melanoma Res; 1993 Feb; 3(1):35-41. PubMed ID: 8471835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic organization of the melanoma-associated glycoprotein MUC18: implications for the evolution of the immunoglobulin domains.
    Sers C; Kirsch K; Rothbächer U; Riethmüller G; Johnson JP
    Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8514-8. PubMed ID: 8378324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer invasion is influenced more by expression of a CD44 isoform including variant 9 than by Muc18.
    Omara-Opyene AL; Qiu J; Shah GV; Iczkowski KA
    Lab Invest; 2004 Jul; 84(7):894-907. PubMed ID: 15107804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of homeobox gene-GBX2 in human prostatic cancer cells.
    Gao AC; Isaacs JT
    Prostate; 1996 Dec; 29(6):395-8. PubMed ID: 8977637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The progression associated antigen MUC18: a unique member of the immunoglobulin supergene family.
    Johnson JP; Rothbächer U; Sers C
    Melanoma Res; 1993 Oct; 3(5):337-40. PubMed ID: 8292890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling of differential expression of messenger RNA in normal, benign, and metastatic prostate cell lines.
    Chakrabarti R; Robles LD; Gibson J; Muroski M
    Cancer Genet Cytogenet; 2002 Dec; 139(2):115-25. PubMed ID: 12550771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of AP-2 results in up-regulation of MCAM/MUC18 and an increase in tumor growth and metastasis of human melanoma cells.
    Jean D; Gershenwald JE; Huang S; Luca M; Hudson MJ; Tainsky MA; Bar-Eli M
    J Biol Chem; 1998 Jun; 273(26):16501-8. PubMed ID: 9632718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tazarotene-induced gene 1 (TIG1) expression in prostate carcinomas and its relationship to tumorigenicity.
    Jing C; El-Ghany MA; Beesley C; Foster CS; Rudland PS; Smith P; Ke Y
    J Natl Cancer Inst; 2002 Apr; 94(7):482-90. PubMed ID: 11929948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the human prostatic carcinoma oncogene PTI-1 by rapid expression cloning and differential RNA display.
    Shen R; Su ZZ; Olsson CA; Fisher PB
    Proc Natl Acad Sci U S A; 1995 Jul; 92(15):6778-82. PubMed ID: 7542776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent and increased expression of human METCAM/MUC18 in cancer tissues and metastatic lesions is associated with the clinical progression of human ovarian carcinoma.
    Wu GJ; Dickerson EB
    Taiwan J Obstet Gynecol; 2014 Dec; 53(4):509-17. PubMed ID: 25510693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis.
    Xie S; Luca M; Huang S; Gutman M; Reich R; Johnson JP; Bar-Eli M
    Cancer Res; 1997 Jun; 57(11):2295-303. PubMed ID: 9187135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ectopic expression of MCAM/MUC18 increases in vitro motility and invasiveness, but decreases in vivo tumorigenesis and metastasis of a mouse melanoma K1735-9 subline in a syngeneic mouse model.
    Wu GJ
    Clin Exp Metastasis; 2016 Dec; 33(8):817-828. PubMed ID: 27510563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel human prostate-specific cDNA: molecular cloning, expression, and immunobiology of the recombinant protein.
    Naz RK; Santhanam R; Tyagi N
    Biochem Biophys Res Commun; 2002 Oct; 297(5):1075-84. PubMed ID: 12372395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.